Resources
The below resources can further assist healthcare providers to educate patients about Restless Legs Syndrome (RLS) and MIRAPEX:
Patient Education materials can help patients better understand RLS and its treatment
Related Links provides a listing of suggested websites for further information about RLS
Get your patients started on MIRAPEX with a Patient Starter Kit
Get your patients started on MIRAPEX with a Patient Starter Kit
Familiarize yourself with three typical patient case studies reflective of diagnosing restless legs syndrome. Learn more
Familiarize yourself with three typical patient case studies reflective of diagnosing restless legs syndrome. Learn more
IMPORTANT SAFETY INFORMATION ABOUT MIRAPEX: MIRAPEX tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
MIRAPEX may cause patients to fall asleep without any warning, even while doing normal daily activities, such as driving. When taking MIRAPEX, hallucinations may occur and sometimes patients may feel dizzy, sweaty or nauseated upon standing up. The most common side effects in clinical trials for RLS were nausea, headache, and tiredness. Patients should talk with their doctor if they experience these problems.
Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease and RLS.
This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.
Please see full Prescribing Information, including patient information.
